Genome Editing White Paper Coming in July

We are almost ready to share the next AABME white paper, Genome Editing and Biomanufacturing, by Gang Bao, a pioneer in nanomedicine, molecular imaging, and the emerging area of genome editing.

July 20, 2017

To utilize the growing availability of genome-wide data and increasingly powerful bioinformatics, it is necessary to develop equally powerful molecular tools to rapidly and precisely manipulate genomic content. These abilities have led to genome editing, a new field in engineering and life sciences focusing on precisely modifying genomes using engineered nucleases.

Sign up now for AABME's white paper series to receive the new white paper, Genome Editing and Biomanufacturing, authored by leading expert Gang Bao at Rice University.

Related Content

WEBINAR SERIES: 3D Printing at the Point of Care

AABME is conducting a series of webinars to examine a risk-based, conceptual framework developed by the US Food and Drug Administration (FDA) for use at point-of-care manufacturing facilities. Webinar panels will include speakers from diverse groups, including medical device manufacturers, point-of-care manufacturers, technology developers, and the FDA. The framework includes the following scenarios: A. Minimal Risk 3DP by a Healthcare Professional B&C. Device Designed by Manufacturer Using Validated Process D. Manufacturer Co-Located at Point of Care E. Healthcare Facility Becomes a Manufacturer
WEBINAR: Simplifying Quality Systems for Tissue Engineering Success: Lessons from the Nuclear Power Industry

In the tissue engineering industry there is a lot of discussion around the complexities of seeding adherent cells, the best modes for generating vascularized scaffolds, the challenges associated with the packaging and transport of tissue-engineered medical products (TEMPs), and how to get your product to market quickly.
WEBINAR: Virtual Reality: A Brief Review of the Future

This presentation will provide a brief description of the various forms of VR technology and describe the trajectory of Clinical VR over the last 20 years addressing health and clinical treatment of anxiety disorders, PTSD, pain management, autism, and in the assessment/rehabilitation of stroke, brain injury, and other neurologically-based conditions. We will also discuss advances in Virtual Human technology for clinical training, healthcare coaching, and clinical interviewing.

Browse similar articles

WEBINAR SERIES: 3D Printing at the Point of Care

AABME is conducting a series of webinars to examine a risk-based, conceptual framework developed by the US Food and Drug Administration (FDA) for use at point-of-care manufacturing facilities. Webinar panels will include speakers from diverse groups, including medical device manufacturers, point-of-care manufacturers, technology developers, and the FDA. The framework includes the following scenarios: A. Minimal Risk 3DP by a Healthcare Professional B&C. Device Designed by Manufacturer Using Validated Process D. Manufacturer Co-Located at Point of Care E. Healthcare Facility Becomes a Manufacturer

View Now

WEBINAR: Simplifying Quality Systems for Tissue Engineering Success: Lessons from the Nuclear Power Industry

In the tissue engineering industry there is a lot of discussion around the complexities of seeding adherent cells, the best modes for generating vascularized scaffolds, the challenges associated with the packaging and transport of tissue-engineered medical products (TEMPs), and how to get your product to market quickly.

View Now